Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2202083A vaccine in healthy infants
NCT00871741Phase 2Terminated
- Sponsor
- GSK
- Start
- Apr 2009
- Primary completion
- Jun 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GSK2202083A in Tetanus, poliomyelitis, meningococcal disease, Haemophilus influenzae type b infection (Hib), diphtheria, sponsored by GSK. Started Apr 2009; status: terminated.
02
Drugs
GSK2202083A
03
Conditions
Tetanuspoliomyelitismeningococcal diseaseHaemophilus influenzae type b infection (Hib)diphtheria
Beyond the preview
Go deeper on NCT00871741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00871741.